PHARMACEUTICAL PREPARATION MANUFACTURING
NAICS 325412 includes $2,566,333,693 in federal contract obligations across 87 ingested award records.
NAICS Snapshot
Total obligations$2,566,333,693
Award records87
Entity code325412
Data updatedMay 7, 2026
Spending by Fiscal Year
| FY202620 awards | $1,177,657,773 |
| FY202522 awards | $2,532,943 |
| FY202410 awards | $7,741,959 |
| FY20234 awards | $470,043 |
| FY20222 awards | $62,541 |
| FY202129 awards | $1,377,868,433 |
Top Contractors
| MCKESSON CORPORATION17 awards | $1,177,370,615 |
| PHLOW CORP.1 awards | $696,665,954 |
| EMERGENT BIOSOLUTIONS CANADA INC2 awards | $678,720,348 |
| RLS (USA) INC.3 awards | $3,592,488 |
| ADVANCED ACCELERATOR APPLICATIONS USA INC5 awards | $2,203,543 |
| MEDI-PHYSICS, INC.2 awards | $1,907,351 |
| PROGENICS PHARMACEUTICALS INC2 awards | $1,191,408 |
| CARDINAL HEALTH 414, LLC5 awards | $948,688 |
| INO THERAPEUTICS LLC1 awards | $759,707 |
| CARDINAL HEALTH 108, LLC1 awards | $611,031 |
Top Agencies
| Department of Health and Human Services21 awards | $1,376,754,134 |
| Department of Veterans Affairs26 awards | $1,187,818,683 |
| Department of Justice18 awards | $1,707,666 |
| Department of Defense21 awards | $43,030 |
| Department of Homeland Security1 awards | $10,181 |
Recent Awards
| Award | Recipient | Fiscal year | Obligations | Date |
|---|---|---|---|---|
| 36C24026K1006 | MCKESSON CORPORATION | 2026 | $1,175,683,451 | Not available |
| 75A50120C00092 | PHLOW CORP. | 2021 | $696,665,954 | Not available |
| 75A50119C00037 | EMERGENT BIOSOLUTIONS CANADA INC | 2021 | $422,315,784 | Not available |
| 75A50119C00075 | EMERGENT BIOSOLUTIONS CANADA INC | 2021 | $256,404,564 | Not available |
| 36C24724C0063 | RLS (USA) INC. | 2024 | $2,317,816 | Not available |
| 36C25624N0975 | MEDI-PHYSICS, INC. | 2024 | $1,847,391 | Not available |
| 36C26124N0090 | ADVANCED ACCELERATOR APPLICATIONS USA INC | 2024 | $1,819,183 | Not available |
| 36C26224P0297 | RLS (USA) INC. | 2024 | $1,127,038 | Not available |
| 36C26325N0537 | CARDINAL HEALTH 414, LLC | 2025 | $761,645 | Not available |
| 36C25921F0086 | INO THERAPEUTICS LLC | 2021 | $759,707 | Not available |
Source: USAspending.gov. Last updated from ingested federal spending data: May 7, 2026.